Ruth McDermott, PhD Sartorius Stedim Biotech Group

Ruth joined Sartorius’ Regenerative Medicine Applications Unit in 2017.

Ruth’s strategic marketing responsibilities include positioning Sartorius as a solution provider for cell and gene therapy applications.

Before joining Sartorius, Ruth has held business development roles at Agilent Technologies, GE Healthcare, Life Technologies and Novozymes Biopharma. Ruth’s scientific knowledge has been built on a background of research in cell bioprocessing, stem cells and gene therapy.

Ruth holds a PhD in Cell Biology and an MBA.